This article is more than 5 years old. Information may no longer be current.

Benvenue Medical announces a new chief operating officer

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Benvenue Medical announced recently that Jeffrey Jones has joined the company as chief operating officer.

The position was newly created for Jones, who has more than 20 years of operations experience with medical technology start-ups and Fortune 500 companies, according to a company press release.

“Jeff brings a wealth of experience in scaling the operations of medical device companies,” Robert Weigle, CEO of Benvenue Medical, said in the press release. “We’re happy to have Jeff join our senior management team as we continue to drive commercialization of the Kiva VCF Treatment System, as well as our other current and future products.”

Jones previously served as vice president of operations at Acclarent, acquired by Johnson & Johnson in January 2010, where he supported rapid sales growth and was responsible for supply chain, manufacturing operations, process engineering, materials, purchasing, facilities, and environmental health and safety. He has also held chief operating officer positions at a number of Bay Area medical device startups, including Polyremedy, Reliant Technologies and Lumend, according to the release.